Metabiota is a San Francisco-based company with over a decade of experience in helping industries and governments worldwide prepare for and manage epidemic risks. With additional offices in Washington DC, Cameroon, and the Democratic Republic of the Congo, Metabiota operates on a global scale. The company specializes in providing data, analytics, advice, and training to support decision-makers in making informed, data-driven choices to protect public health and ensure global health security.

Metabiota serves a diverse range of clients, including corporate entities, insurance companies, government agencies, and multilateral organizations. The company operates in the public health and epidemic risk management market, focusing on estimating, mitigating, and managing the risks associated with epidemics. This is crucial as epidemics can have devastating impacts on both lives and economies.

The business model of Metabiota revolves around offering a suite of services that include data collection and analysis, risk assessment, and strategic advisory. They also provide training programs to help organizations build resilience against potential health threats. By leveraging their expertise in various scientific disciplines such as epidemiology, veterinary medicine, laboratory science, data science, actuarial science, social science, and political economics, Metabiota delivers comprehensive solutions to its clients.

Metabiota generates revenue through the sale of its data and analytics services, consulting fees, and training programs. The company has been recognized for its innovative solutions, winning several awards such as Catastrophe Risk Modelling Solution of the Year 2020 and Insurtech Impact 25 in 2019.

In summary, Metabiota is a key player in the field of epidemic risk management, providing essential tools and insights to help organizations worldwide prepare for and mitigate the impacts of global health threats.

Keywords: Epidemic Risk, Data Analytics, Public Health, Global Security, Consulting, Training, Insurance, Government, Multilateral, Innovation.